Kyverna Therapeutics (KYTX) Earnings Analysis
Kyverna Therapeutics (KYTX) next reports earnings on 2026-08-11, consensus EPS -0.67 USD. Last quarter (2026-03-26) it beat with EPS -0.8 USD vs -0.845 USD est (+5.3%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -2.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does KYTX next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.67 USD |
| Revenue estimate | n/a |
KYTX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | -0.8 USD | -0.845 USD | +5.3% | Beat |
| 2025-11-12 | -0.85 USD | -0.97 USD | +12.4% | Beat |
| 2024-11-13 | -0.8 USD | -0.77 USD | -3.9% | Miss |
| 2024-08-12 | -0.67 USD | -0.7 USD | +4.3% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
KYTX valuation and analyst view
| Trailing P/E | -2.26 |
|---|---|
| Trailing EPS | -2.58794 USD |
| Price / book | 2.29 |
| Dividend yield | 0.00% |
| Market cap | 0.32B |
| Analyst consensus | Buy (4 buy / 0 hold / 0 sell) |
| Avg price target | 25 USD |
Related research pages
Frequently asked questions
When is Kyverna Therapeutics (KYTX)'s next earnings date?
Kyverna Therapeutics is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.67 USD.
Did KYTX beat earnings last quarter?
In its 2026-03-26 report, KYTX posted EPS of -0.8 USD versus a -0.845 USD estimate — a beat of 5.3%.
What is KYTX's earnings track record?
Over the last 4 reported quarters with consensus data, KYTX beat estimates 3 times (75%).
What is KYTX's current P/E ratio and EPS?
KYTX trades at a trailing P/E of -2.26 on trailing EPS of -2.587938617537752 USD.
What do analysts rate KYTX?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 25 USD.